Table 1.
Information of candidate drugs for each lncRNA subtype
| LncRNA subtypes | Numbers of drugs | Numbers of drugs only for one subtype | Numbers of drugs shared with other subtypes | lncRNA subtypes sharing drugs | Drugs shared with other subtypes |
|---|---|---|---|---|---|
| C1 | 33 | 31 | 2 | C1; C2 | BMS-536924 |
| C1; C2; C6; C7 | TW-37 | ||||
| C2 | 18 | 13 | 5 | C1; C2 | BMS-536924 |
| C2; C6 | AMD-070 | ||||
| MSX-122 | |||||
| Plerixafor | |||||
| C1; C2; C6; C7 | TW-37 | ||||
| C3 | 45 | 44 | 1 | C3; C6; C7 | R547 |
| C4 | 39 | 38 | 1 | C4; C5 | Curcumin |
| C5 | 16 | 13 | 3 | C4; C5 | Curcumin |
| C5; C6 | Canfosfamide | ||||
| Ezatiostat | |||||
| C6 | 34 | 22 | 12 | C1; C2; C6; C7 | TW-37 |
| C2; C6 | AMD-070 | ||||
| MSX-122 | |||||
| Plerixafor | |||||
| C3; C6; C7 | R547 | ||||
| C5; C6 | Canfosfamide | ||||
| Ezatiostat | |||||
| C6; C7 | ABT-737 | ||||
| Obatoclax | |||||
| Phosphonothreonine | |||||
| SNS-032 | |||||
| THZ1 | |||||
| C7 | 42 | 35 | 7 | C1; C2; C6; C7 | TW-37 |
| C3; C6; C7 | R547 | ||||
| C6; C7 | ABT-737 | ||||
| Obatoclax | |||||
| Phosphonothreonine | |||||
| SNS-032 | |||||
| THZ1 |